Cambridge Financial Group
ABBV icon

Cambridge Financial Group’s AbbVie ABBV Stock Holding History

Cambridge Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.6M Sell
36,795
-1,231
-3% -$316K 3.41% 12
2026
Q2 		$9.6M Buy
38,026
+860
+2% +$185K 3.33% 15
2026
Q1 		$8.08M Buy
37,166
+355
+1% +$78.7K 3.02% 19
2025
Q4 		$8.41M Sell
36,811
-917
-2% -$209K 3.21% 14
2025
Q3 		$8.74M Buy
37,728
+10,431
+38% +$2.12M 3.39% 14
2025
Q2 		$5.07M Sell
27,297
-10,706
-28% -$1.99M 2.56% 25
2025
Q1 		$7.96M Sell
38,003
-300
-0.8% -$58.3K 3.46% 15
2024
Q4 		$6.81M Buy
+38,303
New +$7.04M 2.81% 24
2024
Q2 		$6.17M Buy
35,981
+2,255
+7% +$374K 2.77% 27
2024
Q1 		$6.14M Buy
33,726
+2,040
+6% +$352K 2.72% 27
2023
Q4 		$4.91M Sell
31,686
-2,634
-8% -$384K 2.46% 28
2023
Q3 		$5.12M Buy
+34,320
New +$5.04M 2.79% 24
2022
Q4 		$5.09M Sell
31,488
-2,085
-6% -$320K 2.84% 22
2022
Q3 		$4.51M Buy
+33,573
New +$4.82M 2.71% 23
2015
Q4 		– Sell
-90,488
Closed -$4.92M – 32
2015
Q3 		$4.92M Sell
90,488
-4,470
-5% -$291K 2.94% 25
2015
Q2 		$6.38M Buy
94,958
+779
+0.8% +$50.9K 3.4% 15
2015
Q1 		$5.51M Buy
94,179
+84,294
+853% +$5.09M 2.73% 30
2014
Q4 		$647K Buy
+9,885
New +$623K 3.15% 24

Other funds holding ABBV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Cambridge Financial Group's ABBV Position: Q3 2026 in Review

Cambridge Financial Group reduced its AbbVie (ABBV) stake by 3.2% in Q3 2026, selling an estimated $316K and leaving 36,795 shares worth $9.6M. The position accounts for 3.41% of the portfolio, ranked #12.

Cambridge Financial Group first reported a position in ABBV in Q4 2014 and has held it in 18 quarters since. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Cambridge Financial Group held 36,795 shares of AbbVie worth $9.6M as of Q3 2026.
  • Cambridge Financial Group sold 1,231 AbbVie shares in Q3 2026, an estimated $316K.
  • AbbVie made up 3.41% of Cambridge Financial Group's portfolio in Q3 2026, its #12 holding.
  • Cambridge Financial Group first reported a position in AbbVie in Q4 2014 and has held it in 18 quarters since.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Cambridge Financial Group's 13F filing for Q3 2026, filed 12 Nov 2026.